These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37976534)

  • 21. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
    Kitajima K; Doi H; Kuribayashi K
    Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.
    Miller R; Mudambi L; Vial MR; Kalhor N; Grosu HB
    Am J Respir Crit Care Med; 2017 Aug; 196(4):e10-e11. PubMed ID: 28510475
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
    Duysinx B; Nguyen D; Louis R; Cataldo D; Belhocine T; Bartsch P; Bury T
    Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 68Ga-Prostate-Specific Membrane Antigen-Avid Malignant Pleural Effusion in a Patient With Metastatic Adenoid Cystic Carcinoma and Concordance With 18F-FDG PET/CT.
    Uijen MJM; Weijers JAM; Driessen CML; van Herpen CML; Nagarajah J
    Clin Nucl Med; 2022 Feb; 47(2):140-141. PubMed ID: 35006109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.
    Duysinx B; Corhay JL; Larock MP; Nguyen D; Bury T; Hustinx R; Louis R
    Nucl Med Commun; 2008 Nov; 29(11):982-6. PubMed ID: 18836376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of FDG PET-CT in differential diagnosis of pleural pathologies.
    Elboga U; Yılmaz M; Uyar M; Zeki Çelen Y; Bakır K; Dikensoy O
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):187-91. PubMed ID: 23067687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma.
    Budak A; Yanarateş A; Budak E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer.
    Alkhawaldeh K; Biersack HJ; Henke A; Ezziddin S
    Clin Nucl Med; 2011 Jun; 36(6):423-8. PubMed ID: 21552017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography.
    Toaff JS; Metser U; Gottfried M; Gur O; Deeb ME; Lievshitz G; Mercer D; Even-Sapir E
    Invest Radiol; 2005 Apr; 40(4):204-9. PubMed ID: 15770138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET imaging in assessing exudative pleural effusions.
    Duysinx BC; Larock MP; Nguyen D; Corhay JL; Bury T; Hustinx R; Louis R
    Nucl Med Commun; 2006 Dec; 27(12):971-6. PubMed ID: 17088683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.
    Zhang X; Duan H; Yu Y; Ma C; Ren Z; Lei Y; He T; Zhang M
    PLoS One; 2018; 13(4):e0193714. PubMed ID: 29641601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Prior JO; Bertagna F; Ceriani L; Giovanella L
    Lung Cancer; 2014 Jan; 83(1):1-7. PubMed ID: 24290256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
    Letovanec I; Allenbach G; Mihaescu A; Nicod Lalonde M; Schmidt S; Stupp R; Fitting JW; Boubaker A; Ris HB; Prior JO
    Nuklearmedizin; 2012; 51(5):186-93. PubMed ID: 22584348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleural dissemination disclosed by 18F-FDG-PET/CT.
    Ohara G; Kagohashi K; Kurishima K; Satoh H
    Intern Med; 2011; 50(16):1783. PubMed ID: 21841348
    [No Abstract]   [Full Text] [Related]  

  • 37. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loco-regional staging of malignant pleural mesothelioma by integrated
    Murphy DJ; Mak SM; Mallia A; Jeljeli S; Stirling JJ; Goh V; Bille A; Cook GJR
    Eur J Radiol; 2019 Jun; 115():46-52. PubMed ID: 31084758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.
    Lococo F; Muoio B; Chiappetta M; Nachira D; Petracca Ciavarella L; Margaritora S; Treglia G
    Contrast Media Mol Imaging; 2020; 2020():5282698. PubMed ID: 32405280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.
    Nguyen NC; Tran I; Hueser CN; Oliver D; Farghaly HR; Osman MM
    Clin Nucl Med; 2009 Dec; 34(12):886-90. PubMed ID: 20139823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.